Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study

Analytical and Bioanalytical Chemistry

Volumn 398, Issue 4, 2010, Pages 1791-1800

  Beer, Beate ^a   Schubert, Birthe ^a   Oberguggenberger, Anne ^a   Meraner, Verena ^a   Hubalek, Michael ^a   Oberacher, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adherence; Anastrozole; Drug monitoring; LC MS MS; Letrozole; Tamoxifen

Indexed keywords

ADHERENCE; ANASTROZOLE; DRUG MONITORING; LC/MS/MS; LETROZOLE; TAMOXIFEN;

DRUG INTERACTIONS; LINEARIZATION; LIQUIDS; MASS SPECTROMETRY; PATIENT MONITORING; PLASMA (HUMAN); PLASMAS; STABILITY CRITERIA;

LIQUID CHROMATOGRAPHY;

ANASTROZOLE; LETROZOLE; NITRILE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TRIAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; EVALUATION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; METHODOLOGY; MIDDLE AGED; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MIDDLE AGED; NITRILES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TANDEM MASS SPECTROMETRY; TRIAZOLES;

EID: 77957840140     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4075-z     Document Type: Article

References (46)

1. GN Hortobagyi SJ de la Garza K Pritchard D Amadori R Haidinger CA Hudis H Khaled MC Liu M Martin M Namer JA O'Shaughnessy ZZ Shen KS Albain 2005 Clin Breast Cancer 6 391 10.3816/CBC.2005.n.043
2. S Hiscox EL Davies P Barrett-Lee 2009 Maturitas 63 275 1:CAS:528:DC%2BD1MXpsF2itrg%3D 10.1016/j.maturitas.2009.05.008
3. TK Choueiri CA Alemany RM Bou-Jawde GT Budd 2004 Clin Ther 26 1199 1:CAS:528:DC%2BD2cXos1ensr4%3D 10.1016/S0149-2918(04)80017-1
4. A Eisen M Trudeau W Shelley H Messersmith KI Pritchard 2008 Cancer Treat Rev 34 157 1:CAS:528:DC%2BD1cXjtl2jtr8%3D 10.1016/j.ctrv.2007.11.001
5. D Hind S Ward NE De E Simpson C Carroll L Wyld 2007 Health Technol Assess 11 1
6. EA Musgrove RL Sutherland 2009 Nat Rev Cancer 9 631 1:CAS:528: DC%2BD1MXhtVegtrzL 10.1038/nrc2713
7. E Robinson GG Kimmick HB Muss 1996 Drugs Aging 8 329 1:CAS:528: DyaK28XntVCntLk%3D 10.2165/00002512-199608050-00002
8. P Conte A Frassoldati 2007 Breast J 13 28 1:CAS:528:DC%2BD2sXitVemsLo%3D 10.1111/j.1524-4741.2006.00359.x
9. EA Perez 2007 Ann Oncol 18 Suppl 8 viii 26
10. S Demissie RA Silliman TL Lash 2001 J Clin Oncol 19 322 1:CAS:528:DC%2BD3MXhtVektrk%3D
11. AK Fink J Gurwitz W Rakowski E Guadagnoli RA Silliman 2004 J Clin Oncol 22 3309 10.1200/JCO.2004.11.064
12. AH Partridge PS Wang EP Winer J Avorn 2003 J Clin Oncol 21 602 1:CAS:528:DC%2BD2cXpsVGrtbs%3D 10.1200/JCO.2003.07.071
13. AH Partridge 2006 Ann Oncol 17 183 1:STN:280:DC%2BD28%2FjvVGktA%3D%3D 10.1093/annonc/mdj141
14. V Ziller M Kalder US Albert W Holzhauer M Ziller U Wagner P Hadji 2009 Ann Oncol 20 431 1:STN:280:DC%2BD1M7mvVynsA%3D%3D 10.1093/annonc/mdn646
15. RT Chlebowski ML Geller 2006 Oncology 71 1 1:CAS:528:DC%2BD2sXktFemt7o%3D
16. K Ruddy E Mayer A Partridge 2009 CA Cancer J Clin 59 56 10.3322/caac.20004
17. P Hadji 2010 Crit Rev Oncol Hematol 73 156 10.1016/j.critrevonc.2009.02. 001
18. ME Larson TM Richards 2009 Clin Med Res 7 134 1:CAS:528: DC%2BC3cXislWhs7c%3D 10.3121/cmr.2009.859
19. AM Van Rossum AS Bergshoeff PL Fraaij PW Hugen NG Hartwig SP Geelen TF Wolfs CM Weemaes R de Groot DM Burger 2002 Pediatr Infect Dis J 21 743 10.1097/00006454-200208000-00009
20. C Hiemke 2008 Eur J Clin Pharmacol 64 159 10.1007/s00228-007-0430-1
21. DJ Touw C Neef AH Thomson AA Vinks 2005 Ther Drug Monit 27 10 1:STN:280:DC%2BD2M7gtFKktQ%3D%3D 10.1097/00007691-200502000-00004
22. J Gjerde ER Kisanga M Hauglid PI Holm G Mellgren EA Lien 2005 J Chromatogr A 1082 6 1:CAS:528:DC%2BD2MXlvVemsb0%3D 10.1016/j.chroma.2005.01.004
23. W Liu L Zhang S Chen H Duan X Chen Z Wei G Chen 2009 Anal Chim Acta 631 47 1:CAS:528:DC%2BD1cXhsVKhsb3N 10.1016/j.aca.2008.10.012
24. C Murphy T Fotsis P Pantzar H Adlercreutz F Martin 1987 J Steroid Biochem 26 547 1:CAS:528:DyaL2sXksFWhtbY%3D 10.1016/0022-4731(87)90006-9
25. SF Teunissen H Rosing RH Koornstra SC Linn JH Schellens AH Schinkel JH Beijnen 2009 J Chromatogr B 877 2519 1:CAS:528:DC%2BD1MXptVCit78%3D 10.1016/j.jchromb.2009.06.029
26. J Zweigenbaum K Heinig S Steinborner T Wachs J Henion 1999 Anal Chem 71 2294 1:CAS:528:DyaK1MXivVakurs%3D 10.1021/ac9813540
27. D de Voss PH Slee RJ Briggs D Stevenson 1998 Cancer Chemother Pharmacol 42 512 10.1007/s002800050854
28. A Decensi S Gandini A Guerrieri-Gonzaga H Johansson L Manetti B Bonanni MT Sandri A Barreca A Costa C Robertson EA Lien 1999 J Clin Oncol 17 2633 1:CAS:528:DyaK1MXmtlWrurg%3D
29. M Dowsett J Cuzick A Howell I Jackson 2001 Br J Cancer 85 317 1:CAS:528:DC%2BD3MXmslSgsbc%3D 10.1054/bjoc.2001.1925
30. KH Lee BA Ward Z Desta DA Flockhart DR Jones 2003 J Chromatogr B 791 245 1:CAS:528:DC%2BD3sXkt1Orsr0%3D 10.1016/S1570-0232(03)00218-6
31. J MacCallum J Cummings JM Dixon WR Miller 1996 J Chromatogr B 678 317 1:CAS:528:DyaK28XjtFeitrc%3D 10.1016/0378-4347(95)00530-7
32. C Apostolou Y Dotsikas C Kousoulos YL Loukas 2008 J Pharm Biomed Anal 48 853 1:CAS:528:DC%2BD1cXht1ymsL%2FF 10.1016/j.jpba.2008.06.006
33. GD Mendes D Hamamoto J Ilha AS Pereira G De Nucci 2007 J Chromatogr B 850 553 1:CAS:528:DC%2BD2sXkslOjs7g%3D 10.1016/j.jchromb.2006.11.044
34. J Rodriguez-Flores AM Contento Salcedo MJ Villasenor Llerena FL Munoz 2008 Electrophoresis 29 811 1:CAS:528:DC%2BD1cXjtFCktr4%3D 10.1002/elps. 200700446
35. JN Ingle AU Buzdar DJ Schaid MP Goetz A Batzler ME Robson DW Northfelt JE Olson EA Perez Z Desta RA Weintraub CV Williard DA Flockhart RM Weinshilboum 2010 Cancer Res 70 3278 1:CAS:528:DC%2BC3cXkslShuro%3D 10.1158/0008-5472.CAN-09- 3024
36. M Dowsett C Pfister SR Johnston DW Miles SJ Houston JA Verbeek H Gundacker A Sioufi IE Smith 1999 Clin Cancer Res 5 2338 1:CAS:528: DyaK1MXmsFyjs74%3D
37. CU Pfister A Martoni C Zamagni G Lelli F De Braud C Souppart M Duval U Hornberger 2001 Biopharm Drug Dispos 22 191 1:CAS:528:DC%2BD3MXptlKqur4%3D 10.1002/bdd.273
38. FT Peters OH Drummer F Musshoff 2007 Forensic Sci Int 165 216 1:CAS:528:DC%2BD2sXltV2ksw%3D%3D 10.1016/j.forsciint.2006.05.021
39. H Oberacher A Krajete W Parson CG Huber 2000 J Chromatogr A 893 23 1:CAS:528:DC%2BD3cXmtlOnurY%3D 10.1016/S0021-9673(00)00731-7
40. BK Matuszewski ML Constanzer CM Chavez-Eng 2003 Anal Chem 75 3019 1:CAS:528:DC%2BD3sXltV2jsL8%3D 10.1021/ac020361s
41. D Dadgar PE Burnett 1995 J Pharm Biomed Anal 14 23 1:CAS:528: DyaK28XjtFalur0%3D 10.1016/0731-7085(95)01634-1
42. E Koster 2005 The Peak August 2005 5
43. H Oberacher M Pavlic K Libiseller B Schubert M Sulyok R Schuhmacher E Csaszar HC Kofeler 2009 J Mass Spectrom 44 485 1:CAS:528:DC%2BD1MXls1Squ7w%3D 10.1002/jms.1545
44. H Oberacher M Pavlic K Libiseller B Schubert M Sulyok R Schuhmacher E Csaszar HC Kofeler 2009 J Mass Spectrom 44 494 1:CAS:528:DC%2BD1MXls1Squ70%3D 10.1002/jms.1525
45. CU Pfister M Duval J Godbillon G Gosset D Gygax F Marfil A Sioufi B Winkler 1994 J Pharm Sci 83 520 1:CAS:528:DyaK2cXhvVaiu7k%3D 10.1002/jps.2600830415
46. AU Buzdar JF Robertson W Eiermann JM Nabholtz 2002 Cancer 95 2006 1:CAS:528:DC%2BD38XovFSqsL4%3D 10.1002/cncr.10908